APA (7th ed.) Citation

Oleynikov, V. E., Budanova, V. A., & Kulucin, A. V. (2016). CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. Столичная издательская компания.

Chicago Style (17th ed.) Citation

Oleynikov, V. E., V. A. Budanova, and A. V. Kulucin. CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. Столичная издательская компания, 2016.

MLA (9th ed.) Citation

Oleynikov, V. E., et al. CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. Столичная издательская компания, 2016.